FTC sues key pharmacy gain managers about insulin rates The agency introduced motion versus Caremark, Express Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the listing cost of lifetime-preserving insulin medicine. Since some electronic health and fitness startups funded in the course of the peak https://label-the-figure-with-the94938.eedblog.com/30744954/not-known-details-about-healthcare-news